ProfileGDS5678 / 1435722_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 9% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.238869
GSM967853U87-EV human glioblastoma xenograft - Control 22.203218
GSM967854U87-EV human glioblastoma xenograft - Control 32.200478
GSM967855U87-EV human glioblastoma xenograft - Control 42.149618
GSM967856U87-EV human glioblastoma xenograft - Control 52.143218
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.251838
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.208468
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.170548
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.160568
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.185828
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.181858
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.1678
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.193448
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.183548